Discovery CT

high-definition images and drastically reduced radiation dose

Only four hospitals in the world have Discovery CT. Policlinico di Monza, together with three other hospitals in France and in the USA, is a leader in terms of advanced technology.
Discovery CT 750 HD –VEO 128 slices performs scans with unprecedented clarity and significantly lower radiation than common CT equipment.

With the introduction of two dose-saving techniques called Adaptive Statistical Iterative Reconstruction (ASIR) and  VEO, radiation dose can be reduced by up to 50% and 90% respectively. This means that oncologic patients are now exposed to less radiation. During lung cancer scanning procedures performed with conventional equipment patients would receive a radiation dose of  6.5 millisievert (mSv). With Discovery CT they only receive 0.11 mSv.

VEO is a new software technology that has enabled a real breakthrough in low-dose imaging.
A name to trust as VEO  means “to see” in Spanish.
Significantly lower doses are also given during head and face scans and at the same time greater profile clarity and definition are achieved even in the case of injuries of not more than 3mm diameter.

Cancer patients receiving a post-operatory follow-up can benefit from a dose reduction of approximately 70%.
Another exceptionally advanced software we use in CT scans is MAR (Metal Artifact Reduction). MAR is a correction technology that addresses the challenges posed by metal artifacts, such as metal prostheses and enables clinicians to clearly delineate between tumors and healthy tissues. Besides, the Bone & Detail software and HD technology reveal details obscured by calcified vessels or metal stents.
Diagnosis is also made easier thanks to a new application, Gemstone Spectral Imaging (GSI). This futuristic software is based on a  dual energy system which proves extremely useful to evaluate tissue composition. It is indeed a step forward in determining whether a cancer is benign or malignant cancer. Complete diagnosis,  however, still requires biopsy.

News dal Gruppo

Il 13-14-15 maggio 2022 presso il palazzo del Parlamento Rumeno di Bucarest si è tenuta la conferenza nazionale “Équipe medica multidisciplinare: il sistema privato - partner...
In occasione della Settimana Mondiale della Tiroide, 23-27 Maggio 2022, il Policlinico di Monza, limitatamente alla sede del Poliambulatorio di Endocrinologia e Malattie del Metabolismo di Via...
Il Dott. Stefano Ciardullo del Centro di Diabetologia, Endocrinologia e Malattie del Metabolismo del Policlinico di Monza, ha pubblicato sulla rivista Diabetes Research and Clinical Practice l’...